Working… Menu

Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01879163
Recruitment Status : Completed
First Posted : June 17, 2013
Last Update Posted : December 16, 2014
Information provided by (Responsible Party):
University of Oxford